Global Cancer Vaccine Market & Clinical Trials Outlook 2028: Featuring Key Players AstraZeneca, BioNTech, Merck & Others
July 26, 2022 07:43 ET
|
Research and Markets
Dublin, July 26, 2022 (GLOBE NEWSWIRE) -- The "Global Cancer Vaccine Market & Clinical Trials Outlook 2028" report has been added to ResearchAndMarkets.com's offering. The global cancer...
Cancer Vaccines Analytical Tool 2022: Gain a Competitive Edge in your Cancer Vaccine Drug Surveillance and Intelligence
June 28, 2022 04:48 ET
|
Research and Markets
Dublin, June 28, 2022 (GLOBE NEWSWIRE) -- The "Cancer Vaccines: Analytical Tool" report has been added to ResearchAndMarkets.com's offering. Cancer Vaccines: Analytical Tool is the must have...
Global Cancer Vaccine Platforms Market Research Report 2022 Featuring eTheRNA, Merck's Keytruda, Moderna, GSK, OSE Immunotherapuetics, Northwest Biotherapeutics, Sanofi, BioNtech, & Roche
May 12, 2022 04:38 ET
|
Research and Markets
Dublin, May 12, 2022 (GLOBE NEWSWIRE) -- The "Cancer Vaccine Platforms" report has been added to ResearchAndMarkets.com's offering. This report forecasts that cancer vaccines market will witness a...
Global Cancer Vaccines Global Markets, Analysis, Competitive Landscape & Forecasts, 2016-2021, 2021-2026F, 2031F
April 19, 2022 04:53 ET
|
Research and Markets
Dublin, April 19, 2022 (GLOBE NEWSWIRE) -- The "Cancer Vaccines Global Market Report 2022: By Type, By Technology, By Cancer, By End-User" report has been added to ResearchAndMarkets.com's offering....
Global Neoantigen Cancer Vaccine Market Report 2022: Focus on Approach, Line of Therapy, Type, Application, Treatment Strategy and Country-Wise Analysis
April 18, 2022 04:18 ET
|
Research and Markets
Dublin, April 18, 2022 (GLOBE NEWSWIRE) -- The "Global Neoantigen Cancer Vaccine Market Analysis and Forecasts 2024-2031" report has been added to ResearchAndMarkets.com's offering. The neoantigen...
Global Cancer Vaccine Partnering Deal Terms and Agreements Report/Directory 2021: Details of the Latest Cancer Vaccine Agreements Announced Since 2010
March 21, 2022 07:23 ET
|
Research and Markets
Dublin, March 21, 2022 (GLOBE NEWSWIRE) -- The "Global Cancer Vaccine Partnering Terms and Agreements 2010-2021" report has been added to ResearchAndMarkets.com's offering. The Global Cancer Vaccine...
Global Human Papillomavirus Vaccine Market (2021 to 2026) - by Type, Indication, Diseases and Geography
November 25, 2021 07:23 ET
|
Research and Markets
Dublin, Nov. 25, 2021 (GLOBE NEWSWIRE) -- The "Global Human Papillomavirus Vaccine Market (2021-2026) by Type, Indication, Diseases, Geography, Competitive Analysis and the Impact of Covid-19 with...
Global Cancer Vaccine Markets to 2026: Approvals for Additional Indications, Competition, Increased Funding, Manufacturers' Strategies, Challenges in Cancer Vaccines
August 13, 2021 06:33 ET
|
Research and Markets
Dublin, Aug. 13, 2021 (GLOBE NEWSWIRE) -- The "Cancer Vaccines: Technologies and Global Markets 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global market for cancer...
Global $1.75 Bn Neoantigen Cancer Vaccine Markets, 2020-2022 & 2023-2026
July 30, 2021 05:58 ET
|
Research and Markets
Dublin, July 30, 2021 (GLOBE NEWSWIRE) -- The "Global Neoantigen Cancer Vaccine Market, By Product, By Neoantigen Type, By Route of Administration, By Cell, By Technology, By Delivery Mechanism, By...
Human Papillomavirus (HPV) Vaccines Disease Report 2021: Guidelines, Pipeline, Regulatory Events, Clinical Trials, Marketed Vaccines
July 08, 2021 06:43 ET
|
Research and Markets
Dublin, July 08, 2021 (GLOBE NEWSWIRE) -- The "Disease Analysis: Human Papillomavirus (HPV) Vaccines" report has been added to ResearchAndMarkets.com's offering. Since the launch of the first HPV...